Natixis Advisors LLC lessened its stake in shares of Leidos Holdings, Inc. (NYSE:LDOS - Free Report) by 21.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 180,805 shares of the aerospace company's stock after selling 49,946 shares during the quarter. Natixis Advisors LLC owned approximately 0.14% of Leidos worth $29,471,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently made changes to their positions in LDOS. Empirical Finance LLC lifted its holdings in shares of Leidos by 2.3% during the 3rd quarter. Empirical Finance LLC now owns 4,492 shares of the aerospace company's stock valued at $732,000 after purchasing an additional 103 shares during the last quarter. CIBC Asset Management Inc increased its position in Leidos by 10.7% during the 3rd quarter. CIBC Asset Management Inc now owns 20,195 shares of the aerospace company's stock valued at $3,292,000 after buying an additional 1,957 shares in the last quarter. OneDigital Investment Advisors LLC raised its stake in Leidos by 82.1% in the third quarter. OneDigital Investment Advisors LLC now owns 5,359 shares of the aerospace company's stock valued at $874,000 after buying an additional 2,416 shares during the last quarter. Metis Global Partners LLC boosted its holdings in Leidos by 51.5% in the third quarter. Metis Global Partners LLC now owns 6,358 shares of the aerospace company's stock worth $1,036,000 after acquiring an additional 2,161 shares in the last quarter. Finally, KBC Group NV grew its stake in shares of Leidos by 23.7% during the third quarter. KBC Group NV now owns 13,869 shares of the aerospace company's stock worth $2,261,000 after acquiring an additional 2,658 shares during the last quarter. 76.12% of the stock is currently owned by hedge funds and other institutional investors.
Leidos Price Performance
Shares of NYSE:LDOS traded down $1.81 during trading on Monday, reaching $158.84. 2,736,247 shares of the company's stock traded hands, compared to its average volume of 912,450. The firm has a market cap of $21.19 billion, a PE ratio of 18.30, a P/E/G ratio of 1.08 and a beta of 0.68. Leidos Holdings, Inc. has a fifty-two week low of $104.72 and a fifty-two week high of $202.90. The company has a quick ratio of 1.15, a current ratio of 1.23 and a debt-to-equity ratio of 0.87. The company has a 50-day simple moving average of $169.55 and a 200-day simple moving average of $155.65.
Leidos (NYSE:LDOS - Get Free Report) last announced its earnings results on Tuesday, October 29th. The aerospace company reported $2.93 earnings per share for the quarter, topping the consensus estimate of $1.96 by $0.97. Leidos had a return on equity of 30.31% and a net margin of 7.37%. The business had revenue of $4.19 billion during the quarter, compared to the consensus estimate of $4.06 billion. During the same period in the prior year, the company posted $2.03 EPS. The business's quarterly revenue was up 6.9% on a year-over-year basis. As a group, analysts predict that Leidos Holdings, Inc. will post 10.07 earnings per share for the current year.
Leidos Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Monday, December 16th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Monday, December 16th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.01%. This is a boost from Leidos's previous quarterly dividend of $0.38. Leidos's payout ratio is currently 17.31%.
Insider Buying and Selling
In other Leidos news, Director Surya N. Mohapatra sold 2,748 shares of the stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $194.97, for a total value of $535,777.56. Following the completion of the sale, the director now owns 20,001 shares in the company, valued at approximately $3,899,594.97. This represents a 12.08 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert C. Kovarik, Jr. sold 1,047 shares of the company's stock in a transaction that occurred on Thursday, October 31st. The shares were sold at an average price of $184.94, for a total value of $193,632.18. Following the completion of the sale, the director now owns 6,408 shares of the company's stock, valued at $1,185,095.52. This trade represents a 14.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.96% of the company's stock.
Analysts Set New Price Targets
Several analysts have weighed in on the stock. JPMorgan Chase & Co. boosted their target price on shares of Leidos from $175.00 to $185.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 2nd. Royal Bank of Canada upped their target price on Leidos from $145.00 to $180.00 and gave the company a "sector perform" rating in a research report on Wednesday, October 30th. Bank of America boosted their price target on Leidos from $160.00 to $165.00 and gave the company a "buy" rating in a research note on Wednesday, August 7th. The Goldman Sachs Group raised their price objective on Leidos from $205.00 to $228.00 and gave the stock a "buy" rating in a research note on Wednesday, October 30th. Finally, TD Cowen upped their target price on Leidos from $175.00 to $200.00 and gave the company a "buy" rating in a research report on Wednesday, October 30th. Two analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $191.23.
View Our Latest Stock Report on LDOS
Leidos Company Profile
(
Free Report)
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Featured Articles
Before you consider Leidos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Leidos wasn't on the list.
While Leidos currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report